BDBM5293 4-({2-[(5-cyano-1,3-thiazol-2-yl)amino]-3-methylpyridin-4-yl}methyl)-N-methylpiperazine-1-carboxamide::4-[2-(5-Cyanothiazol-2-ylamino)-3-methylpyridin-4-yl-methyl]piperazine-1-carboxylic Acid Methylamide::N-(1,3-Thiazol-2-yl)pyridin-2-amine 23

SMILES CNC(=O)N1CCN(Cc2ccnc(Nc3ncc(s3)C#N)c2C)CC1

InChI Key InChIKey=WVBVFBWFVVPNPZ-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 5293   

TargetVascular endothelial growth factor receptor 2(Human)
Merck Research Laboratories

LigandPNGBDBM5293(4-[2-(5-Cyanothiazol-2-ylamino)-3-methylpyridin-4-...)
Affinity DataIC50: 12nMpH: 7.4 T: 2°CAssay Description:Activated KDR was incubated with 25 uM/10 uCi of [gamma-33P] ATP, poly-Glu/Tyr, and inhibitors in kinase buffer for 15 min at 22 °C. The reactio...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/9/2005
Entry Details Article
PubMed